All this knowledge can be applied in developing STING ligands that can result in drugs able to modulate cellular processes involved in the induction of antiviral responses, control autoimmune diseases, or adjuvants for improving vaccination and cancer therapies. The gene discussed is STING1; the disease is cancer.